Cargando…
The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy
SIMPLE SUMMARY: The aim of the present study is to determine the prognostic impact of ABO blood types on the survival of a Japanese population of patients with HCC who underwent surgical resection. We retrospectively analyzed 480 patients with HCC who had R0 resection between 2010 and 2020. Outcomes...
Autores principales: | Kaibori, Masaki, Yoshii, Kengo, Matsui, Kosuke, Matsushima, Hideyuki, Kosaka, Hisashi, Yamamoto, Hidekazu, Nakajima, Takayoshi, Aoi, Kazunori, Yamaguchi, Takashi, Yoshida, Katsunori, Sekimoto, Mitsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251914/ https://www.ncbi.nlm.nih.gov/pubmed/37296868 http://dx.doi.org/10.3390/cancers15112905 |
Ejemplares similares
-
Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
por: Kaibori, Masaki, et al.
Publicado: (2022) -
Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2021) -
Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases
por: Kaibori, Masaki, et al.
Publicado: (2022) -
Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
por: Yamamoto, Hidekazu, et al.
Publicado: (2023) -
The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2021)